Cargando…
Pharyngitis
Most infectious pharyngitis has a viral cause. The use of aspirin or nonsteroidal antiinflammatory agents (NSAIAs) is advised in adults and NSAIAs in children for the treatment of pain. There are several studies that show that NSAIAs relieve pharyngitis pain better than acetaminophen. Penicillin rem...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119355/ https://www.ncbi.nlm.nih.gov/pubmed/24439883 http://dx.doi.org/10.1016/j.pop.2013.10.010 |
| _version_ | 1783514754007957504 |
|---|---|
| author | Weber, Ruth |
| author_facet | Weber, Ruth |
| author_sort | Weber, Ruth |
| collection | PubMed |
| description | Most infectious pharyngitis has a viral cause. The use of aspirin or nonsteroidal antiinflammatory agents (NSAIAs) is advised in adults and NSAIAs in children for the treatment of pain. There are several studies that show that NSAIAs relieve pharyngitis pain better than acetaminophen. Penicillin remains the antibiotic of choice of group A beta-hemolytic streptococcal (GAS) pharyngitis. Resistance has not developed to penicillin. Patients with GAS pharyngitis should have improvement in 3 to 4 days. If not better at that time, the patient should be seen for diagnostic reconsideration or the development of a suppurative complication. |
| format | Online Article Text |
| id | pubmed-7119355 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71193552020-04-08 Pharyngitis Weber, Ruth Prim Care Article Most infectious pharyngitis has a viral cause. The use of aspirin or nonsteroidal antiinflammatory agents (NSAIAs) is advised in adults and NSAIAs in children for the treatment of pain. There are several studies that show that NSAIAs relieve pharyngitis pain better than acetaminophen. Penicillin remains the antibiotic of choice of group A beta-hemolytic streptococcal (GAS) pharyngitis. Resistance has not developed to penicillin. Patients with GAS pharyngitis should have improvement in 3 to 4 days. If not better at that time, the patient should be seen for diagnostic reconsideration or the development of a suppurative complication. Elsevier Inc. 2014-03 2013-11-20 /pmc/articles/PMC7119355/ /pubmed/24439883 http://dx.doi.org/10.1016/j.pop.2013.10.010 Text en Copyright © 2014 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Weber, Ruth Pharyngitis |
| title | Pharyngitis |
| title_full | Pharyngitis |
| title_fullStr | Pharyngitis |
| title_full_unstemmed | Pharyngitis |
| title_short | Pharyngitis |
| title_sort | pharyngitis |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119355/ https://www.ncbi.nlm.nih.gov/pubmed/24439883 http://dx.doi.org/10.1016/j.pop.2013.10.010 |
| work_keys_str_mv | AT weberruth pharyngitis |